|
| 35064522 | A Medicare Claims Analysis of Racial and Ethnic Disparities in the Access to Radiation Therapy Services. | J Racial Ethn Health Disparities | 2023 |
| 36898417 | The American Society for Radiation Oncology Workforce Taskforce Review of the United States Radiation Oncology Workforce Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 36657498 | Recent Trends in Medicare Payments for Outpatient Cancer Care at the End of Life. | Int J Radiat Oncol Biol Phys | 2023 |
| 34774650 | Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. | Radiother Oncol | 2022 |
| 35963472 | ASTRO Supports Access to Evidence-Based Cancer Care for All Patients, Regardless of Pregnancy Status, and Protection for Physicians Recommending and Providing Evidence-Based Care. | Int J Radiat Oncol Biol Phys | 2022 |
| 34836735 | Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. | Clin Oncol (R Coll Radiol) | 2022 |
| 33035622 | Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. | Radiother Oncol | 2021 |
| 34529516 | Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims. | JCO Oncol Pract | 2021 |
| 34524836 | Radiation Oncology's Place in Payment Reform: ASTRO Advocates for a Place at the Table. | JCO Oncol Pract | 2021 |
| 34585025 | Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. | Adv Radiat Oncol | 2021 |
| 33412264 | Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties. | Int J Radiat Oncol Biol Phys | 2021 |
| 32171462 | The ASTRO Perspective on "Impact of Patient Stage and Disease Characteristics on the Proposed Radiation Oncology Alternative Payment Model (RO-APM) at a Large Academic Cancer Center". | Int J Radiat Oncol Biol Phys | 2020 |
| 32000833 | Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy. | Radiat Oncol | 2020 |
| 31978591 | Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial. | Pract Radiat Oncol | 2020 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 30735235 | Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. | JAMA Netw Open | 2019 |
| 32529134 | Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. | Adv Radiat Oncol | 2019 |
| 31276777 | Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2019 |
| 28951089 | Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. | Pract Radiat Oncol | 2018 |
| 28209443 | Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. | Int J Radiat Oncol Biol Phys | 2017 |
| 27511849 | Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. | Int J Radiat Oncol Biol Phys | 2016 |
| 26600011 | Regional Nodal Irradiation: Examining the Clinical Implications of Randomized Trials. | Am J Clin Oncol | 2016 |
| 27663760 | Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. | Int J Radiat Oncol Biol Phys | 2016 |
| 27890426 | Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. | Radiother Oncol | 2016 |
| 27528591 | Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5Â years from a multicenter retrospective study. | Brachytherapy | 2016 |
| 27260487 | Re: Han et al. | Clin Oncol (R Coll Radiol) | 2016 |
| 25450032 | Combining immunotherapy and radiation for prostate cancer. | Clin Genitourin Cancer | 2015 |
| 26276528 | Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. | Radiother Oncol | 2015 |
| 26054865 | Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2015 |
| 25035197 | Design and implementation of bundled payment systems for cancer care and radiation therapy. | Int J Radiat Oncol Biol Phys | 2014 |
| 25452933 | A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up. | Front Oncol | 2014 |
| 25525842 | The promise of combining radiation therapy and immunotherapy: morbidity and toxicity. | Future Oncol | 2014 |
| 25525840 | Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions. | Future Oncol | 2014 |
| 23302902 | Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer. | Cancer Control | 2013 |
| 24674505 | In Vivo Verification as a Tool to Tailor Daily IGRT and Flag Adaptive Radiotherapy. | Pract Radiat Oncol | 2013 |
| 24674502 | Advancing Image Guided Visualization of Cellular-based Vaccines, In Vivo, During Combined Radiation/Immunotherapy Protocols. | Pract Radiat Oncol | 2013 |
| 21517127 | Dose-volume factors to select patient-specific image-guidance action thresholds in prostate cancer. | Technol Cancer Res Treat | 2011 |
| 22162711 | The confluence of stereotactic ablative radiotherapy and tumor immunology. | Clin Dev Immunol | 2011 |
| 20052734 | Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy. | Cancer | 2010 |
| 20153881 | Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study. | Urology | 2010 |
| 15607149 | Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis. | Brachytherapy | 2004 |
| 11324767 | Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. | Cancer J | 2001 |
| 11332146 | Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. | Ann Oncol | 2001 |
| 10439169 | Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. | Cancer J Sci Am | 1999 |
| 9112452 | Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. | Int J Radiat Oncol Biol Phys | 1997 |